Shanghai Junshi Biosciences Management
Management criteria checks 3/4
Shanghai Junshi Biosciences' CEO is Cong Li, appointed in Nov 2021, has a tenure of 7.92 years. total yearly compensation is CN¥4.22M, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 0.013% of the company’s shares, worth HK$3.61M. The average tenure of the management team and the board of directors is 3.2 years and 5.4 years respectively.
Key information
Cong Li
Chief executive officer
CN¥4.2m
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 3yrs |
| CEO ownership | 0.01% |
| Management average tenure | 3.2yrs |
| Board average tenure | 5.4yrs |
Recent management updates
Recent updates
Shanghai Junshi Biosciences Co., Ltd.'s (HKG:1877) Price Is Right But Growth Is Lacking After Shares Rocket 35%
Oct 14
Is Shanghai Junshi Biosciences (HKG:1877) Using Debt Sensibly?
Sep 30Shanghai Junshi Biosciences Co., Ltd.'s (HKG:1877) Revenues Are Not Doing Enough For Some Investors
Aug 29Shanghai Junshi Biosciences (HKG:1877) Has Debt But No Earnings; Should You Worry?
Jun 28Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Shares Fly 27% But Investors Aren't Buying For Growth
May 06Is Shanghai Junshi Biosciences (HKG:1877) Using Debt Sensibly?
Mar 22Risks Still Elevated At These Prices As Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Shares Dive 29%
Jan 26Is Shanghai Junshi Biosciences (HKG:1877) A Risky Investment?
Dec 17Is Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Trading At A 38% Discount?
Nov 20Health Check: How Prudently Does Shanghai Junshi Biosciences (HKG:1877) Use Debt?
Sep 05Revenues Not Telling The Story For Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)
May 22Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Shares Could Be 35% Below Their Intrinsic Value Estimate
May 01A Look At The Intrinsic Value Of Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)
Jan 16Some Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Analysts Just Made A Major Cut To Next Year's Estimates
Nov 03Is Shanghai Junshi Biosciences (HKG:1877) A Risky Investment?
Oct 12CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -CN¥2b |
| Jun 30 2024 | n/a | n/a | -CN¥2b |
| Mar 31 2024 | n/a | n/a | -CN¥2b |
| Dec 31 2023 | CN¥4m | CN¥4m | -CN¥2b |
| Sep 30 2023 | n/a | n/a | -CN¥2b |
| Jun 30 2023 | n/a | n/a | -CN¥2b |
| Mar 31 2023 | n/a | n/a | -CN¥3b |
| Dec 31 2022 | CN¥4m | CN¥4m | -CN¥2b |
Compensation vs Market: Cong's total compensation ($USD595.59K) is about average for companies of similar size in the Hong Kong market ($USD505.66K).
Compensation vs Earnings: Cong's compensation has increased whilst the company is unprofitable.
CEO
Cong Li (60 yo)
3yrs
Tenure
CN¥4,224,000
Compensation
Mr. Cong Li has been Co-Chief Executive Officer and Executive Director at Shanghai Junshi Biosciences Co., Ltd. since November 2, 2021 and served as Non-Executive Director since December 22, 2016 until Nov...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 9.7yrs | CN¥8.50m | 13.09% HK$ 3.7b | |
| Co-CEO & Executive Director | 3yrs | CN¥4.22m | 0.013% HK$ 3.6m | |
| GM, CEO & Executive Director | less than a year | CN¥5.86m | no data | |
| Executive Vice-Chairman of the Board | 6.4yrs | CN¥9.93m | 0.0051% HK$ 1.4m | |
| Financial Director | 4yrs | CN¥2.73m | 0.00071% HK$ 198.8k | |
| Deputy GM & Executive Director | no data | CN¥8.13m | 0.88% HK$ 245.9m | |
| Senior VP & Executive Director | no data | CN¥8.01m | no data | |
| Deputy GM | 5.3yrs | CN¥1.32m | 0.0010% HK$ 285.7k | |
| Executive Director | less than a year | no data | 0.0096% HK$ 2.7m | |
| Assistant to GM & Chief of Internal Audit Department | 4yrs | no data | no data | |
| Chief Commercial Officer | 3.3yrs | no data | no data | |
| Chief Medical Officer | no data | no data | no data |
3.2yrs
Average Tenure
51.5yo
Average Age
Experienced Management: 1877's management team is considered experienced (3.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 9.7yrs | CN¥8.50m | 13.09% HK$ 3.7b | |
| Co-CEO & Executive Director | 7.9yrs | CN¥4.22m | 0.013% HK$ 3.6m | |
| GM, CEO & Executive Director | 2.4yrs | CN¥5.86m | no data | |
| Executive Vice-Chairman of the Board | 6.4yrs | CN¥9.93m | 0.0051% HK$ 1.4m | |
| Deputy GM & Executive Director | 7.9yrs | CN¥8.13m | 0.88% HK$ 245.9m | |
| Senior VP & Executive Director | 7.9yrs | CN¥8.01m | no data | |
| Deputy GM | 1.1yrs | CN¥1.32m | 0.0010% HK$ 285.7k | |
| Executive Director | 1.1yrs | no data | 0.0096% HK$ 2.7m | |
| Non-Executive Director | 9.5yrs | no data | 0.74% HK$ 207.1m | |
| Independent Non-Executive Director | 4.4yrs | CN¥200.00k | no data | |
| Independent Non-Executive Director | 2.9yrs | CN¥200.00k | no data | |
| Chairman of the Board of Supervisors | less than a year | no data | no data |
5.4yrs
Average Tenure
57yo
Average Age
Experienced Board: 1877's board of directors are considered experienced (5.4 years average tenure).